InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by BERGER FRANKLIN M, Directeur Juridique. Officer active across 2 companies, notably Kezar Life Sciences, Inc.. Aggregated, 5 reports have been recorded. Total volume traded: €308k. The latest transaction was filed on 18 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€215,68515,000 shares@ €14.3790.40% mcap70.6% of flow
Common Stock
SEC:0001209191-22-020584:0·
Ideal exit: 13 Dec 2022 (T+270)
€44,8488,896 shares@ €5.0414100.0% of flow
Common Stock
SEC:0001209191-21-057418·
€46,1833,786 shares@ €12.1983100.0% of flow
Common Stock
SEC:0000899243-21-037351·
Ideal exit: 18 Jun 2022 (T+270)
€44,8488,896 shares@ €5.04140.083% mcap14.7% of flow
Common Stock
SEC:0001209191-21-057418:0·
€46,1833,786 shares@ €12.19830.32% mcap50.0% of flow
Common Stock
SEC:0000899243-21-037351:0·
Ideal exit: 18 Jun 2022 (T+270)
5 of 5 declarations
About BERGER FRANKLIN M
Zoran Zdraveski is Chief Legal Officer at TScan Therapeutics, Inc. He is responsible for managing legal affairs and regulatory compliance. His role is essential in protecting the company's interests and ensuring adherence to applicable laws and regulations.
